A David Burden Selected Research

A David Burden Research Topics

Disease

27	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 10/2004
3	Skin Diseases (Skin Disease) 04/2021 - 03/2012
3	Inflammation (Inflammations) 01/2018 - 11/2016
2	Infections 12/2021 - 01/2016
2	Psoriatic Arthritis 01/2019 - 11/2015
1	Atopic Dermatitis (Atopic Eczema) 10/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2019
1	Wounds and Injuries (Trauma) 01/2018
1	Necrosis 01/2016
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2012
1	Nephrogenic Fibrosing Dermopathy 09/2010
1	Crohn Disease (Crohn's Disease) 09/2007

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 12/2021 - 11/2015
5	Biological ProductsIBA 11/2019 - 11/2015
4	Ustekinumab (CNTO 1275)FDA Link 11/2020 - 01/2018
4	Adalimumab (Humira)FDA Link 01/2019 - 01/2016
4	HLA-C Antigens (HLA-C)IBA 01/2019 - 10/2004
2	spesolimabIBA 12/2021 - 01/2021
2	Peroxidase (Myeloperoxidase)IBA 04/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 11/2019 - 01/2019
2	CC ChemokinesIBA 01/2018 - 01/2017
2	Etanercept (Enbrel)FDA Link 01/2018 - 01/2016
2	ChemokinesIBA 01/2018 - 01/2017
2	Chemokine ReceptorsIBA 01/2018 - 01/2017
2	Chemokine Receptor D6IBA 01/2018 - 01/2017
2	CytokinesIBA 11/2016 - 01/2016
1	RNA (Ribonucleic Acid)IBA 10/2022
1	ConnexinsIBA 06/2021
1	Prostaglandins AIBA 11/2020
1	AntibodiesIBA 11/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2020
1	Immunologic Factors (Immunomodulators)IBA 11/2019
1	Monoclonal AntibodiesIBA 05/2019
1	secukinumabIBA 05/2019
1	Interleukin-17 (Interleukin 17)IBA 05/2019
1	Interleukin-12 (IL 12)IBA 01/2019
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Proteins (Proteins, Gene)FDA Link 11/2017
1	Imiquimod (Aldara)FDA LinkGeneric 01/2017
1	Interleukin-1 (Interleukin 1)IBA 11/2016
1	RetinoidsIBA 01/2016
1	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 05/2014
1	Toll-Like Receptor 3IBA 05/2014
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 05/2014
1	HLA-C*06 antigenIBA 05/2011
1	GadoliniumIBA 09/2010
1	Contrast MediaIBA 09/2010
1	Betamethasone (Celestone)FDA Link 09/2008
1	N 556IBA 09/2008
1	calcipotriene (calcipotriol)FDA LinkGeneric 09/2008
1	LigandsIBA 09/2007
1	Interleukin-23 (Interleukin 23)IBA 09/2007
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2005

Therapy/Procedure

7	Biological Therapy 01/2021 - 11/2015
3	Therapeutics 01/2022 - 12/2015
1	Phototherapy (Light Therapy) 01/2016
1	Precision Medicine 03/2012